 |
PDBsum entry 3qw6
|
|
|
|
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
 |
|
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
|
|
|
|
|
|
|
Hydrolase/hydrolase inhibitor
|
PDB id
|
|
|
|
3qw6
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
PDB id:
|
 |
|
 |
| Name: |
 |
Hydrolase/hydrolase inhibitor
|
 |
|
Title:
|
 |
Crystal structure of the protease domain of botulinum neurotoxin serotype a with a peptide inhibitor rygc
|
|
Structure:
|
 |
Botulinum neurotoxin type a. Chain: a. Fragment: light chain (unp residues 1-424). Synonym: bont/a, bontoxilysin-a, botox. Engineered: yes. Inhibitory peptide rygc. Chain: b. Engineered: yes
|
|
Source:
|
 |
Clostridium botulinum. Organism_taxid: 441771. Strain: hall / atcc 3502 / nctc 13319 / type a. Gene: bota, cbo0806, clc_0862. Expressed in: escherichia coli. Expression_system_taxid: 469008. Synthetic: yes
|
|
Resolution:
|
 |
|
1.60Å
|
R-factor:
|
0.205
|
R-free:
|
0.222
|
|
|
Authors:
|
 |
D.Kumaran,S.Swaminathan
|
|
Key ref:
|
 |
G.Kumar
et al.
(2012).
Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling.
Acta Crystallogr D Biol Crystallogr,
68,
511-520.
PubMed id:
|
 |
|
Date:
|
 |
|
26-Feb-11
|
Release date:
|
08-Feb-12
|
|
|
|
|
|
PROCHECK
|
|
|
|
|
Headers
|
 |
|
|
References
|
|
|
|
|
|
|
P0DPI1
(BXA1_CLOBH) -
Botulinum neurotoxin type A from Clostridium botulinum (strain Hall / ATCC 3502 / NCTC 13319 / Type A)
|
|
|
|
Seq: Struc:
|
 |
 |
 |
1296 a.a.
422 a.a.
|
|
|
|
|
|
|
|
|
 |
 |
|
|
Key: |
 |
PfamA domain |
 |
 |
 |
Secondary structure |
 |
 |
CATH domain |
 |
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.69
- bontoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
Acta Crystallogr D Biol Crystallogr
68:511-520
(2012)
|
|
PubMed id:
|
|
|
|
|
| |
|
Peptide inhibitors of botulinum neurotoxin serotype A: design, inhibition, cocrystal structures, structure-activity relationship and pharmacophore modeling.
|
|
G.Kumar,
D.Kumaran,
S.A.Ahmed,
S.Swaminathan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
');
}
}
 |